MADRIGAL PHARMACEUTICALS, INC. Other Non-Current Assets
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Other Non-Current Assets of $21.11 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-07-30
- 2026-06-30: Other Assets, Noncurrent $21.11M.
- 2026-03-31: Other Assets, Noncurrent $23.50M.
- 2025-12-31: Other Assets, Noncurrent $0.00.
- 2015-09-30: Other Assets, Noncurrent $226.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $21.11M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $23.50M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $0.00 10-Q · filed 2026-07-30 |
| 2015-09-30 | $226.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $278.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $564.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $305.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $331.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $358.00K 10-Q · filed 2014-08-06 |
| 2014-03-31 | $384.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.41M 10-K · filed 2015-03-12 |
| 2013-09-30 | $433.00K 10-Q · filed 2013-11-04 |
| 2013-06-30 | $464.00K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $481.00K 10-Q · filed 2013-04-30 |
| 2012-12-31 | $458.00K 10-K · filed 2014-03-11 |
| 2012-09-30 | $466.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $503.00K 10-Q · filed 2012-08-02 |
| 2012-03-31 | $519.00K 10-Q · filed 2012-05-03 |
| 2011-12-31 | $631.00K 10-K · filed 2013-03-14 |
| 2011-09-30 | $530.00K 10-Q · filed 2011-11-03 |
| 2011-06-30 | $497.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $366.00K 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |